Medical Communications

A team of researchers at Washington University School of Medicine (WUSM) in St Louis and the Eunice Kennedy Shriver National …

Paul Workman, Chief Executive and President of the Institute of Cancer Research, examines the spiralling cost of cancer treatments and …

Another week, another busy week in pharma. The last seven days have seen some remarkable strides in the diabetes space, …

Great news in the cardiovascular space as results from the National Heart Failure Audit indicate that better treatment has led …

Pharmaceutical production has long been the object of scrutiny to ensure the highest levels of quality and safety are maintained. …

In the first large-scale study of its kind, a team of researchers at Boston Medical Center’s Grayken Center for Addiction …

Alvotech, a biopharmaceutical company focusing on the development and manufacture of based in Reykjavik, Iceland, has replaced outgoing CEO, Eef …

Moderna Therapeutics, a clinical stage biotechnology company, has appointed Juan Andres to the position of Senior Vice President of Late …

NHS England has announced that it will finally make the HIV-preventing drug, PrEP, available to those at risk with the …

Jeff Huber, a former Google executive who spent 14 years at the company, has announced that he will step from …

Another week passes by, and the headlines have seen some shocking stories, such as the news that the UK is …

Bristol-Myers Squibb has agreed a deal to acquire IFM Therapeutics for a potential $2.3 billion. The latter is a biotech …

Celgene is celebrating following NICE’s announcement that it had decided to recommend the use of nab-Paclitaxel, when used in combination …

Facebook CEO Mark Zuckerberg and philanthropist Priscilla Chan have continued their quest to improve worldwide healthcare with the latest donation …

There are currently no treatments that are able to slow the development of Parkinson’s disease. This unmet medical need will …